Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Arius Announces First Quarter Fiscal 2007 Financial Results
May 1st, 2007
ARIUS Research Inc., ("ARIUS" or the "Company") (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced its financial and operational results for the first quarter, ended February 28, 2007. "Our primary focus for 2007 will be to advance ARIUS-originated antibodies towards clinical development," said Dr. David Young, President and CEO. "During the quarter, we focused on moving our three lead antibody programs into pre-IND enabling studies in preparation for toxicology studies later in 2007 and human clinical trials planned for 2008. We also continued to support our numerous research partnerships, delivering...
Source: Cancer Weekly (2007-05-01)
|
